- Molecules
- 12
MedsAcross lists 12 molecules linked to Invasive ductal carcinoma, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- AnastrozoleAromatase Inhibitor2 presentations1 brandL02BG03
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- FluorouracilOrphanNucleoside Metabolic Inhibitor13 presentations3 brandsL01BC02
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- CapecitabineNucleoside Metabolic Inhibitor3 presentations6 brandsL01BC06
- GemcitabineNucleoside Metabolic Inhibitor13 presentations2 brandsL01BC05
- LetrozoleAromatase Inhibitor2 presentations1 brandL02BG04
- TrastuzumabOrphanHER2/neu Receptor Antagonist14 presentations18 brandsL01FD01
- ExemestaneOrphanAromatase Inhibitor2 presentations1 brandL02BG06
- EpirubicinOrphanAnthracycline Topoisomerase Inhibitor2 presentations1 brandL01DB03
- OntruzantBiologic1 presentationL01XC03
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Invasive ductal carcinoma?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.